Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 12,400
-120 (-0.96%)
At close: Oct 24, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 149.04 billion as of October 24, 2025. Its market cap has decreased by -14.36% in one year.
Market Cap
149.04B
Enterprise Value
216.81B
Revenue
14.33B
Ranking
n/a
PE Ratio
33.50
Stock Price
12,400.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 149.04B, a decrease of -58.67%. That is a compound annual growth rate of -18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 149.04B | -17.94% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 83.84T |
| Celltrion | 38.09T |
| ALTEOGEN | 23.85T |
| Yuhan | 8.54T |
| SK Biopharmaceuticals | 8.34T |
| Peptron | 6.00T |
| HLB Co., Ltd. | 5.98T |
| PharmaResearch | 5.69T |